CD8A and neoplasm: Cross-presentation, a process that DCs undergo in order to activate CD8+ T cells, plays a major role in generating anti-tumor immunity (11), however; when DCs of tumor-bearing hosts undergo this vital process, T cell tolerance often results (5).